Skip to main content
DNA Labs India

STT3A Gene Congenital disorder of glycosylation, type Iw NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

STT3A Gene Congenital disorder of glycosylation, type Iw NGS Genetic Test

Short Name: STT3A CDG Type Iw NGS Test

Also known as: CDG Type Iw, STT3A-CDG, Congenital Glycosylation Disorder Type Iw

STT3A Gene Congenital disorder of glycosylation, type Iw NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3-4 weeks. Free home collection in 300+ cities across India.

Genetic TestUnisex🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the STT3A Gene CDG Type Iw NGS Genetic Test is to confirm a diagnosis of Congenital Disorder of Glycosylation Type Iw by detecting pathogenic variants in the STT3A gene. This helps in understanding the genetic basis of symptoms, guiding treatment plans, and providing information for family planning and genetic counseling.

Test Code
1952
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3-4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. Ensure genetic counseling session is scheduled for family history assessment.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in the arm, or a finger prick for FTA card collection.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding. Resume normal activities unless otherwise advised.

Timeline: 3-4 weeks

Patient Instructions

1
Before the Test:Genetic counseling to discuss test implications and obtain informed consent.
2
During the Test:Sample collection via blood draw or FTA card; analysis using NGS technology.
3
After the Test:Review results with genetic counselor; initiate management based on findings.

About This Test

Who Should Get This Test

The purpose of the STT3A Gene CDG Type Iw NGS Genetic Test is to confirm a diagnosis of Congenital Disorder of Glycosylation Type Iw by detecting pathogenic variants in the STT3A gene. This helps in understanding the genetic basis of symptoms, guiding treatment plans, and providing information for family planning and genetic counseling.

How to Prepare

  • Schedule appointment for sample collection
  • Provide clinical history and family pedigree chart
  • For blood sample, avoid excessive physical activity before collection
  • Ensure proper labeling of samples

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is vital for early diagnosis of rare metabolic disorders in children, enabling timely management and family counseling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs per sample type
ContainerEDTA tube or FTA card
Collection MethodVenipuncture

Sample Stability

Ambient temperatureUp to 48 hours for blood samples
Extracted DNAStable for years if stored properly
Sample Rejection Criteria:
  • Sample hemolyzed or clotted
  • Insufficient volume
  • Improperly labeled or stored samples

Understanding Your Results

Interpretation of the STT3A Gene CDG Type Iw NGS Genetic Test results requires analysis of detected genetic variants in the context of the patient's clinical presentation and family history.
📊

No pathogenic variants detected

Negative result; does not completely rule out CDG but suggests low genetic risk

📊

Pathogenic variant detected

Positive result confirming diagnosis of CDG Type Iw; implications for management and family counseling

📊

Variant of uncertain significance

Further testing or family studies may be needed for clarification

⚠️ When to Consult a Doctor:

Consult a doctor or genetic specialist if the test is positive, if symptoms persist, or for guidance on management and family planning.

Limitations

  • May not detect all possible genetic variants or mutations
  • Cannot predict disease severity or progression accurately
  • Results require interpretation by a qualified geneticist

Risks & Considerations

  • Minor bruising at puncture site
  • Rare risk of infection
  • Emotional impact of genetic results

Interfering Factors

  • Poor sample quality or contamination
  • Insufficient DNA quantity
  • Previous blood transfusions affecting DNA integrity

Compare With Similar Tests

TestSTT3A Gene Congenital disorder of glycosylation, type Iw NGS Genetic TestPMM2 Gene CDG Type Ia NGS TestMetabolic Disorder Gene Panel
ComparisonSTT3A Gene Congenital disorder of glycosylation, type Iw NGS Genetic TestFocuses on a different gene for CDG Type Ia; similar cost and technologyBroader panel including multiple genes for various metabolic disorders

Frequently Asked Questions

What is the STT3A Gene CDG Type Iw NGS Genetic Test?
It is a genetic test that uses Next-Generation Sequencing to analyze the STT3A gene for mutations causing Congenital Disorder of Glycosylation Type Iw, a rare metabolic disorder.
Who should consider this test?
Individuals with symptoms like developmental delays, seizures, liver issues, or a family history of CDG should consider this test.
How is the test performed?
The test involves collecting a blood sample or extracted DNA, which is then analyzed using NGS technology to detect gene variants.
What is the cost of the test?
The test costs INR 20000 at DNA Labs India, with home sample collection available.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
What do the results mean?
Results indicate the presence or absence of pathogenic variants in the STT3A gene. A positive result confirms CDG Type Iw diagnosis, while a negative result may require further evaluation.
Is the test covered by insurance?
Coverage varies by insurance provider and scheme; it is recommended to check with your insurer.
What are the risks of the test?
Risks are minimal, primarily related to blood draw, such as bruising or infection. Emotional impact of results should be considered.
Can this test be done at home?
Yes, DNA Labs India offers free home sample collection in many cities across India for online bookings.
What treatments are available if the test is positive?
There is no cure for CDG, but treatments focus on managing symptoms, including therapies and medications for specific issues like seizures.
How accurate is the NGS genetic test?
NGS is highly accurate for detecting known mutations, but it may not identify all genetic variants. Interpretation by a geneticist is essential.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.